Updates

National Vaccination Day: Origin and Significance

National Vaccination Day is observed annually on March 16 to commemorate the first administration of the Oral Polio Vaccine (OPV) in 1995 under India’s Pulse Polio Programme. This day highlights India’s sustained efforts in immunisation, which have led to the eradication of diseases like smallpox and polio, and the elimination of maternal and neonatal tetanus. It underscores the country’s transformation into a global vaccine manufacturing hub and reflects robust public health policy and institutional capacity.

UPSC Relevance

  • GS Paper 2: Health Sector – National Health Policies, Immunisation Programmes, Right to Health
  • GS Paper 3: Science and Technology – Vaccine Development, Disease Eradication, Public Health Infrastructure
  • Essay: Role of Immunisation in Public Health and India’s Global Vaccine Leadership

The immunisation programme in India operates under a layered legal and policy framework. The Universal Immunisation Programme (UIP), launched in 1985 by the Ministry of Health and Family Welfare (MoHFW), is the principal operational scheme covering 26 vaccine-preventable diseases as of 2023. The Epidemic Diseases Act, 1897 (Sections 2 and 3) empowers central and state governments to implement special measures during outbreaks, including vaccination drives.

The Drugs and Cosmetics Act, 1940 (amended in 2020) regulates vaccine production standards and quality control. The National Vaccine Policy 2011 provides strategic guidelines for vaccine research, development, and deployment. The Supreme Court’s interpretation of the Right to Health under Article 21 (notably in Paschim Banga Khet Mazdoor Samity v. State of West Bengal, 1996) reinforces immunisation as a fundamental right linked to life and dignity.

Economic Dimensions of India’s Vaccine Ecosystem

India’s vaccine market is valued at approximately USD 3 billion, growing at a CAGR of 15% (India Brand Equity Foundation, 2023). The government allocated nearly INR 35,000 crore (~USD 4.5 billion) for COVID-19 vaccination in the 2021-22 Union Budget, reflecting the scale of public investment. India manufactures nearly 60% of the world’s vaccines by volume, positioning itself as the “pharmacy of the world” (WHO, 2023).

Over 200 crore COVID-19 vaccine doses were administered domestically by 2023 (MoHFW), showcasing operational capacity. The vaccine export market contributes over USD 1 billion annually, supporting India’s global supply chain and economic diplomacy.

Key Institutions Driving Immunisation and Vaccine Development

  • MoHFW: Formulates policy and implements UIP nationwide.
  • Indian Council of Medical Research (ICMR): Leads vaccine research and clinical trials.
  • National Institute of Virology (NIV): Conducts surveillance and vaccine quality testing.
  • Serum Institute of India: World’s largest vaccine manufacturer by volume.
  • World Health Organization (WHO): Provides technical guidance and certifies disease eradication.
  • GAVI (Global Alliance for Vaccines and Immunisation): Supports funding and capacity building for immunisation.

Data-Driven Outcomes of India’s Immunisation Efforts

Indicator Value/Year Source
Smallpox eradication in India 1977 WHO
Last polio case reported 2011 WHO
Polio-free certification 2014 WHO
Under-five mortality rate reduction 74 (2015-16) to 41 (2019-21) per 1000 live births NFHS-5
COVID-19 vaccine doses administered 200+ crore (by 2023) MoHFW
Maternal and neonatal tetanus elimination 2015 WHO
Vaccine-preventable diseases covered under UIP 26 (as of 2023) MoHFW

Comparative Analysis: India vs Nigeria in Polio Eradication

Aspect India Nigeria
Last reported polio case 2011 Ongoing cases as of 2023
Polio eradication status Certified polio-free (2014) Not yet certified polio-free
Key challenges Vaccine hesitancy in pockets; cold chain logistics in remote areas Vaccine hesitancy, weak cold chain infrastructure, conflict zones
Programme approach Extensive door-to-door campaigns; robust cold chain management Limited reach in conflict-affected areas; inconsistent immunisation

Critical Gaps in India’s Immunisation Landscape

  • Vaccine hesitancy persists in some rural and tribal regions due to misinformation and cultural beliefs.
  • Cold chain infrastructure remains inadequate in remote and difficult terrains, risking vaccine potency.
  • Uneven immunisation coverage creates pockets of vulnerability, risking disease resurgence.
  • Data quality and real-time monitoring need strengthening for targeted interventions.

Significance and Way Forward

  • National Vaccination Day symbolizes India’s successful public health interventions and the importance of sustained immunisation efforts.
  • Strengthening cold chain logistics and addressing vaccine hesitancy through community engagement are critical to closing coverage gaps.
  • Continued investment in vaccine research, production capacity, and policy adaptation will maintain India’s global vaccine leadership.
  • Integrating digital health technologies can improve monitoring and targeted delivery in underserved areas.
📝 Prelims Practice
Consider the following statements about the Universal Immunisation Programme (UIP):
  1. UIP was launched in 1985 and covers over 20 vaccine-preventable diseases as of 2023.
  2. The Epidemic Diseases Act, 1897, provides legal backing for UIP implementation during outbreaks.
  3. The Drugs and Cosmetics Act, 1940, regulates the quality and production of vaccines in India.

Which of the above statements is/are correct?

  • a1 and 2 only
  • b2 and 3 only
  • c1 and 3 only
  • d1, 2 and 3
Answer: (d)
All three statements are correct. UIP was launched in 1985 and covers 26 diseases as of 2023. The Epidemic Diseases Act, 1897, empowers governments to take special measures including immunisation during outbreaks. The Drugs and Cosmetics Act regulates vaccine production and quality standards.
📝 Prelims Practice
Regarding India’s polio eradication efforts, consider the following:
  1. India was declared polio-free by WHO in 2014 after the last case in 2011.
  2. India’s polio eradication was primarily due to mandatory vaccination under the National Vaccine Policy 2011.
  3. Vaccine hesitancy and cold chain challenges were completely absent in India’s polio campaign.

Which of the above statements is/are correct?

  • a1 only
  • b1 and 2 only
  • c2 and 3 only
  • d1, 2 and 3
Answer: (a)
Statement 1 is correct. India was declared polio-free in 2014 after the last reported case in 2011. Statement 2 is incorrect because the Pulse Polio Programme was the main driver, not the National Vaccine Policy 2011. Statement 3 is incorrect; vaccine hesitancy and cold chain challenges existed but were managed effectively.
✍ Mains Practice Question
Discuss the role of National Vaccination Day in highlighting India’s immunisation achievements and the challenges that remain in ensuring universal vaccine coverage. (250 words)
250 Words15 Marks

Jharkhand & JPSC Relevance

  • JPSC Paper: Paper 2 - Health and Family Welfare; Paper 3 - Science and Technology
  • Jharkhand Angle: Tribal and remote areas in Jharkhand face vaccine hesitancy and cold chain challenges similar to national trends, impacting immunisation coverage.
  • Mains Pointer: Frame answers highlighting state-specific outreach programs, integration of local governance in vaccination drives, and challenges unique to Jharkhand’s geography and demography.
What is the significance of National Vaccination Day in India?

National Vaccination Day, observed on March 16, commemorates the first Oral Polio Vaccine dose administered in 1995 under the Pulse Polio Programme. It marks India’s commitment to immunisation and public health achievements including polio eradication.

Which Act empowers the government to enforce vaccination during epidemics?

The Epidemic Diseases Act, 1897 (Sections 2 and 3) empowers central and state governments to take special measures, including vaccination, during epidemics.

How many vaccine-preventable diseases does the Universal Immunisation Programme cover as of 2023?

As of 2023, the UIP covers immunisation against 26 vaccine-preventable diseases nationwide.

What role does the Serum Institute of India play in vaccination?

The Serum Institute of India is the world’s largest vaccine manufacturer by volume, producing a majority of India’s vaccines and supplying globally, including COVID-19 vaccines.

When was India declared polio-free?

India was declared polio-free by the WHO in 2014 after the last reported polio case in 2011.

Our Courses

72+ Batches

Our Courses
Contact Us